Case Reports

Inadvertent epidural administration of ceftriaxone in a post-cesarean section patient during analgesia top-up

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 12 May 2026
45
Views
26
Downloads

Authors

A 28-year-old ASA II woman underwent elective cesarean section under epidural anesthesia (15 mL 0.5% bupivacaine with 4 µg/mL fentanyl at L3-L4). Postoperatively, she received epidural analgesia with 0.1% bupivacaine plus fentanyl infusion and 1 g IV ceftriaxone 12 hourly for prophylaxis. Six hours after delivery, a nurse inadvertently injected 1 g (10 mL of 10%) ceftriaxone epidurally instead of local anesthetic, due to an unlabeled syringe mix-up.

Immediately, the patient experienced severe pain at the site of incision and lumbar region Numeric Rating Scale (NRS 10/10), with blood pressure rising from 118/68 to 156/92 mmHg and heart rate from 76 to 112 bpm, consistent with intense pain and sympathetic surge rather than direct neurotoxicity. IV pentazocine 30 mg and IM diclofenac 75 mg resolved pain within 3 minutes; moderate sedation (Ramsay 3) occurred but resolved quickly, with vitals stabilizing (Blood Pressure, BP 124/74 mmHg; Heart Rate, HR 88 bpm). Neurological examination remained normal. The epidural filter was flushed with 5 mL saline, and analgesia resumed safely after 30 minutes. No neurological deficits, fever, or infection developed over 48 hours of monitoring; she was discharged on day 4 with no sequelae at 18-weeks follow-up.

This case illustrates medication errors in obstetric units and contrasts the benign outcome of epidural cephalosporin exposure (mild, transient symptoms) with severe risks of intrathecal administration. Strict safety protocols are essential.

Downloads

Download data is not yet available.

Citations

1. Rodrigues GG, Furtado JC, de Oliveira TN, et al. Postoperative epidural analgesia in cesarean section: comparison of therapeutic schemes. Rev Bras Ginecol Obstet 2021;43:95-101.
2. Cousins MJ, Bridenbaugh PO, eds. Neural blockade in clinical anesthesia and management of pain. 3rd ed. Lippincott-Raven; Philadelphia, USA; 1998.
3. Cohen MR, Smetzer JL. Mix-ups between epidural analgesia and IV antibiotics in labor and delivery units continue to cause harm. Hosp Pharm 2019;54:155-9. DOI: https://doi.org/10.1177/0018578719825730
4. Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol 2011;72:381-93. DOI: https://doi.org/10.1111/j.1365-2125.2011.03991.x
5. Sun Z, Xu X, Song Z, et al. Repeated intrathecal administration of ropivacaine causes neurotoxicity in rats. Mol Med Rep 2019;20:4477-84.
6. Fuzier R, Albouzai G, Salomon A, et al. A systematic review of antibiotic administration incidents involving neuraxial routes: clinical analysis, contributing factors and prevention approaches. Pain Ther 2024;13:1-20.
7. Ziegeler S, Raddatz A, Smul R, et al. A systematic review of antibiotic administration incidents involving neuraxial routes. Reg Anesth Pain Med 2023;48:123-30.
8. Paech MJ. Failed epidural: causes and management. Br J Anaesth 2012;109:312-8.
9. Desai N, Gardner A, Carvalho B. Labor epidural analgesia to cesarean section anesthetic conversion failure: a national survey. Anesth Analg 2016;122:2025-31.
10. Lee S, Lew E, Lim Y, et al. Failure of augmentation of labor epidural analgesia for intrapartum cesarean delivery: a retrospective review. Anesth Analg 2017;125:916922.
11. Kim KB, Kim SM, Park W, et al. Ceftriaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review. J Korean Med Sci 2012;27:772-4. DOI: https://doi.org/10.3346/jkms.2012.27.9.1120
12. Grill MF, Herrera J, Koch S. Ceftriaxone-induced acute reversible encephalopathy in a patient with enteric fever. Indian J Pharmacol 2012;44:124-5. DOI: https://doi.org/10.4103/0253-7613.91884
13. Stoeckel K, McNamara PJ, Brandt R, et al. Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clin Pharmacol Ther 1981;29:650-7. DOI: https://doi.org/10.1038/clpt.1981.90
14. Patel IH, Brockerhoff A, Weinfeld RE, et al. Pharmacokinetics of ceftriaxone in humans. Antimicrob Agents Chemother 1981;20:634-41. DOI: https://doi.org/10.1128/AAC.20.5.634
15. Richards DM, Heel RC. Ceftriaxone: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 1984;27:469-527. DOI: https://doi.org/10.2165/00003495-198427060-00001
16. Neu HC. Ceftriaxone: a new parenteral cephalosporin. Med Clin North Am 1987;71:613-24.
17. Patel IH, Miller AK, Weinfeld RE, et al. Multiple intravenous dose pharmacokinetics of ceftriaxone in man. Chemotherapy 1981;27:47-56. DOI: https://doi.org/10.1159/000238029
18. Hayton WL, Stoeckel K. Pharmacokinetics of ceftriaxone in humans. J Clin Pharmacol 1985;25:484-93.
19. Kopacz DJ, Slover RB. Accidental epidural cephazolin injection: safeguards for patientcontrolled analgesia. Anesthesiology 1990;72:944-7. DOI: https://doi.org/10.1097/00000542-199005000-00027
20. Mchaourab A, Ruiz F. Inadvertent caudal epidural injection of cefazolin. Anesth Analg 2000;91:680-1.
21. Stoeckel K, Trueb V, Eggers H, et al. Pharmacokinetics of ceftriaxone in subjects with normal and impaired hepatic function. Clin Pharmacokinet 1983;8:457-66.
22. Jadot L, Judong A, Canivet JL, et al. Ceftriaxone-induced encephalopathy: a pharmacokinetic approach. Eur J Case Rep Intern Med 2021;8:003011. DOI: https://doi.org/10.12890/2021_003011

How to Cite



“Inadvertent Epidural Administration of Ceftriaxone in a Post-Cesarean Section Patient During Analgesia Top-up”. 2026. Pyramid Journal of Medicine 9 (1). https://doi.org/10.4081/pjm.2026.607.